Cargando…
Targeting the undruggable oncogenic KRAS: the dawn of hope
KRAS mutations are the drivers of various cancers, including non–small cell lung cancer, colon cancer, and pancreatic cancer. Over the last 30 years, immense efforts have been made to inhibit KRAS mutants and oncogenic KRAS signaling using inhibitors. Recently, specific targeting of KRAS mutants wit...
Autores principales: | Asimgil, Hande, Ertetik, Utku, Çevik, Nedim Can, Ekizce, Menar, Doğruöz, Alper, Gökalp, Muazzez, Arık-Sever, Elif, Istvanffy, Rouzanna, Friess, Helmut, Ceyhan, Güralp Onur, Demir, Ihsan Ekin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765045/ https://www.ncbi.nlm.nih.gov/pubmed/35014625 http://dx.doi.org/10.1172/jci.insight.153688 |
Ejemplares similares
-
Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
por: Saka, Didem, et al.
Publicado: (2020) -
Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer
por: Goess, Ruediger, et al.
Publicado: (2021) -
Innervated mouse pancreas organoids as an ex vivo model to study pancreatic neuropathy in pancreatic cancer
por: Besikcioglu, H. Erdinc, et al.
Publicado: (2021) -
Nerve-Cancer Interactions in the Stromal Biology of Pancreatic Cancer
por: Demir, Ihsan Ekin, et al.
Publicado: (2012) -
Surgery and the kings of medical science: Invited Commentary: “Publication activity of chief and senior general/visceral surgeons in German university hospitals — a ten-year analysis”, Böckmann et al.
por: Demir, Ihsan Ekin, et al.
Publicado: (2021)